[go: up one dir, main page]

SG11201506713TA - 2-acylaminothiazole derivative and salt thereof - Google Patents

2-acylaminothiazole derivative and salt thereof

Info

Publication number
SG11201506713TA
SG11201506713TA SG11201506713TA SG11201506713TA SG11201506713TA SG 11201506713T A SG11201506713T A SG 11201506713TA SG 11201506713T A SG11201506713T A SG 11201506713TA SG 11201506713T A SG11201506713T A SG 11201506713TA SG 11201506713T A SG11201506713T A SG 11201506713TA
Authority
SG
Singapore
Prior art keywords
salt
acylaminothiazole derivative
acylaminothiazole
derivative
Prior art date
Application number
SG11201506713TA
Inventor
Taisuke Takahashi
Jun Maeda
Yusuke Inagaki
Kenji Negoro
Hiroaki Tanaka
Kazuhiro Yokoyama
Hajime Takamatsu
Takanori Koike
Issei Tsukamoto
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of SG11201506713TA publication Critical patent/SG11201506713TA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • A61K31/497Non-condensed pyrazines containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/107Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
SG11201506713TA 2013-02-28 2014-02-27 2-acylaminothiazole derivative and salt thereof SG11201506713TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013039964 2013-02-28
PCT/JP2014/054803 WO2014133056A1 (en) 2013-02-28 2014-02-27 2-acylaminothiazole derivative and salt thereof

Publications (1)

Publication Number Publication Date
SG11201506713TA true SG11201506713TA (en) 2015-09-29

Family

ID=51428316

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201506713TA SG11201506713TA (en) 2013-02-28 2014-02-27 2-acylaminothiazole derivative and salt thereof

Country Status (23)

Country Link
US (1) US9562044B2 (en)
EP (1) EP2963036B1 (en)
JP (1) JP6183451B2 (en)
KR (1) KR102164821B1 (en)
CN (1) CN105008353B (en)
AR (1) AR094921A1 (en)
AU (1) AU2014221726B2 (en)
BR (1) BR112015020963B1 (en)
CA (1) CA2902302C (en)
EA (1) EA027179B1 (en)
ES (1) ES2748402T3 (en)
IL (1) IL240764A0 (en)
MX (1) MX368539B (en)
MY (1) MY190361A (en)
PH (1) PH12015501899A1 (en)
PL (1) PL2963036T3 (en)
PT (1) PT2963036T (en)
SA (1) SA515360956B1 (en)
SG (1) SG11201506713TA (en)
TW (1) TWI647227B (en)
UA (1) UA118445C2 (en)
WO (1) WO2014133056A1 (en)
ZA (1) ZA201506296B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112016027729B1 (en) * 2014-05-28 2020-11-17 Astellas Pharma Inc. compound derived from pyridine, pharmaceutical composition containing said compound and its use
HUE043496T2 (en) * 2014-06-06 2019-08-28 Astellas Pharma Inc 2-Aminothiazole derivative for use in the prevention or treatment of bladder / urinary tract disorders
CN106573928B (en) * 2014-08-26 2020-04-14 安斯泰来制药株式会社 2-Aminothiazole derivatives or salts thereof
PT3228616T (en) * 2014-12-05 2019-11-21 Astellas Pharma Inc Pyridine derivatives
AR102849A1 (en) * 2015-03-09 2017-03-29 Astellas Pharma Inc BICYCLE PIRIDINE COMPOUND
TW201713343A (en) * 2015-04-28 2017-04-16 安斯泰來製藥股份有限公司 Pharmaceutical composition for oral administration
WO2016183676A1 (en) * 2015-05-20 2016-11-24 Kent Imaging Automatic compensation for the light attenuation due to epidermal melanin in skin images
CA3099655A1 (en) 2018-05-08 2019-11-14 Nippon Shinyaku Co., Ltd. Azabenzimidazole compounds and pharmaceutical
RU2709496C1 (en) * 2019-08-01 2019-12-18 Марат Феликсович Фазылов Method of producing avatrombopag
KR20220100627A (en) 2019-11-13 2022-07-15 니뽄 신야쿠 가부시키가이샤 Azabenzimidazole compounds and medicaments
IL298475A (en) * 2020-06-09 2023-01-01 Anima Biotech Inc Collagen 1 translation inhibitors and methods of use thereof
EP3967311A1 (en) 2020-09-11 2022-03-16 Astellas Pharma Inc. Compounds for use in the treatment of dry mouth

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1466912T3 (en) * 2002-01-18 2013-07-01 Astellas Pharma Inc 2-ACYLAMINOTHIAZOLD DERIVATIVES OR SALTS THEREOF
CN100445281C (en) * 2003-05-02 2008-12-24 诺瓦提斯公司 Quinucidine derivatives that bind to muscarinic M3 receptors
AR044134A1 (en) * 2003-05-02 2005-08-24 Novartis Ag DERIVATIVES OF QUINUCLIDINE, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS.
MXPA06000441A (en) 2003-07-17 2006-04-05 Astellas Pharma Inc 2-acylaminothiazole derivative or salt thereof.
JP4774995B2 (en) * 2005-01-12 2011-09-21 アステラス製薬株式会社 Pharmaceutical composition comprising an acylaminothiazole derivative as an active ingredient
JP4665769B2 (en) 2005-01-12 2011-04-06 アステラス製薬株式会社 Method for producing acylaminothiazole derivative
KR101764952B1 (en) 2010-07-29 2017-08-03 리겔 파마슈티칼스, 인크. Ampk-activating heterocyclic compounds and methods for using the same

Also Published As

Publication number Publication date
AU2014221726B2 (en) 2018-06-28
EA201591391A1 (en) 2016-01-29
ZA201506296B (en) 2017-11-29
ES2748402T3 (en) 2020-03-16
EP2963036A1 (en) 2016-01-06
AU2014221726A1 (en) 2015-09-10
MX2015011202A (en) 2016-05-18
PT2963036T (en) 2019-10-15
JPWO2014133056A1 (en) 2017-02-02
KR102164821B1 (en) 2020-10-13
UA118445C2 (en) 2019-01-25
SA515360956B1 (en) 2016-12-07
EA027179B1 (en) 2017-06-30
TWI647227B (en) 2019-01-11
JP6183451B2 (en) 2017-08-23
BR112015020963B1 (en) 2020-10-27
MY190361A (en) 2022-04-17
TW201522330A (en) 2015-06-16
PH12015501899B1 (en) 2016-01-04
CN105008353A (en) 2015-10-28
EP2963036B1 (en) 2019-08-28
CA2902302C (en) 2021-03-09
AR094921A1 (en) 2015-09-09
US20160002218A1 (en) 2016-01-07
IL240764A0 (en) 2015-10-29
PH12015501899A1 (en) 2016-01-04
CN105008353B (en) 2017-11-10
MX368539B (en) 2019-10-07
EP2963036A4 (en) 2016-08-03
PL2963036T3 (en) 2019-12-31
WO2014133056A1 (en) 2014-09-04
US9562044B2 (en) 2017-02-07
KR20150120516A (en) 2015-10-27
BR112015020963A2 (en) 2017-07-18
HK1214255A1 (en) 2016-07-22
CA2902302A1 (en) 2014-09-04

Similar Documents

Publication Publication Date Title
IL274355B (en) Aza-pyridone compounds and uses thereof
IL240863B (en) Amatoxin derivatives
SG11201506100XA (en) Pyridazinone-amides derivatives
GB2516077B (en) Decoy
GB201323008D0 (en) Compounds and uses thereof
SG11201506713TA (en) 2-acylaminothiazole derivative and salt thereof
ZA201601333B (en) Oxoquinazolinyl-butanamide derivatives
GB201312318D0 (en) Novel methods and compounds
IL244214B (en) Thienopiperidine derivative and use thereof
DK3016978T3 (en) Humane anti-ifn-alpha-antistoffer
GB201307233D0 (en) Compounds and uses thereof
SG11201605189YA (en) Imidazopyrazinone derivatives
DK3016977T3 (en) Humane anti-il-32-antistoffer
GB201309180D0 (en) Compounds and Their Uses
GB201314610D0 (en) Compounds and their uses
GB201306248D0 (en) Compounds and their uses
IL245452B (en) Aramchol salt
GB201320161D0 (en) Compounds and their uses
GB201301393D0 (en) Kiddibidet and pottibidet
GB201323005D0 (en) Compounds and uses thereof
GB201304395D0 (en) Real fit
GB201309248D0 (en) Compounds and combinations